Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Telix Pharmaceuticals Limited

< Previous 1 2 Next >
TLX250-CDx (Zircaix) Included in Leading International Guidelines for Renal Imaging
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
CMS Grants Transitional Pass-Through Status for Gozellix
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix H1 2025 Results: Investor Webcast Notification
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Reports $204M Revenue, Up 63% YOY
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Gozellix Receives Permanent HCPCS Code
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Precision Medicine Announces AlFluor Radiochemistry Platform
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Investor Day in New York City on June 11, 2025: Presenting KOLs
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix to Host Investor Day in New York City on June 11, 2025
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Reports US$186M Q1 Revenue, Up 62% YOY
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Announces Cardinal Health for Gozellix Commercial Distribution
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX CAH TLX
Telix Appoints Paul Schaffer as Chief Technology Officer
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Anne Whitaker Appointed as Non-Executive Director
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX ICLR TLX
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Adds Lead-212 Isotope Production Capability
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.